Selection of tumor antigens as targets for immune attack using immunohistochemistry: I. Focus on gangliosides
Shengle Zhang(Memorial Sloan Kettering Cancer Center), Philip O. Livingston(Memorial Sloan Kettering Cancer Center), Kenneth O. Lloyd(Memorial Sloan Kettering Cancer Center), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Sucharita Adluri(Memorial Sloan Kettering Cancer Center), Wm. Bradley Hamilton(Memorial Sloan Kettering Cancer Center), Helen S. Zhang(Memorial Sloan Kettering Cancer Center), Victor E. Reuter(Memorial Sloan Kettering Cancer Center)
International Journal of Cancer
September 26, 1997
Cited by 278
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Clinical-grade computational pathology using weakly supervised deep learning on whole slide images
|Nature Medicine|2019|2.6k
The Somatic Genomic Landscape of Chromophobe Renal Cell Carcinoma
|Cancer Cell|2014|860
An Integrated Metabolic Atlas of Clear Cell Renal Cell Carcinoma
|Cancer Cell|2016|855